Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WNT5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZIC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC40A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OVOL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LBH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPVL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMCX5-GPRASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNJ4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LTBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on